These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 596235)

  • 1. The effect of dopaminergic drugs on pituitary hormone release in normal subjects.
    Sekso M; Solter M; Banovac K; Vizner B; Petek M
    Acta Med Iugosl; 1977; 31(4):321-32. PubMed ID: 596235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of dopaminergic pharmacological agents on thyrotropic hormone secretion by the hypophysis when stimulated with thyrotropin-releasing hormone].
    Boiadzhieva N; Zakharieva B; Ovcharov R
    Eksp Med Morfol; 1985; 24(1):29-32. PubMed ID: 3928331
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of neuropsychiatric pathology and pharmacology in neuroendocrinologic research].
    Polleri A
    Riv Neurol; 1977; 47(1):1-20. PubMed ID: 16336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
    Delitala G; Masala A; Alagna S; Devilla L
    IRCS J Med Sci; 1975 Jun; 3(6):274. PubMed ID: 1165172
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
    Hietala J; Koulu M; Scheinin M; Syvälahti E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):451-4. PubMed ID: 3935892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of dopamine energic pharmacology drugs on secretion of the adrenocorticotropic hormone from the hypophysis.
    Milkov V; Pironcheva G; Miteva K; Russev G; Zlatarev S
    Microbios; 2000; 102(403):155-8. PubMed ID: 10955829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of catecholaminergic substances on the circular reaction caused by stimulation of the caudate nucleus].
    Dutov AA
    Farmakol Toksikol; 1976; 39(5):537-40. PubMed ID: 1028579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological difference of L-dopa, apomorphine, and bromocriptine against metoclopramide.
    Fang VS
    Life Sci; 1981 May; 28(19):2143-9. PubMed ID: 7253807
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonstriatal dopaminergic neurons: Section XI. Dopaminergic neurons and mental diseases: Introduction: dopaminergic neurons and mental diseases.
    Bunney WE
    Adv Biochem Psychopharmacol; 1977; 16():635-7. PubMed ID: 883562
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of rat prolactin release by apomorphine in vivo and in vitro.
    Smalstig EB; Sawyer BD; Clemens JA
    Endocrinology; 1974 Jul; 95(1):123-9. PubMed ID: 4857693
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of L-DOPA, phentolamine, aminophylline and propranolol on growth hormone secretion in patients with normal anterior pituitary function and subjects with acromegaly].
    De la Fuente E; Souvatzoglou A; von Werder K
    Verh Dtsch Ges Inn Med; 1974; 80():1325-8. PubMed ID: 4454412
    [No Abstract]   [Full Text] [Related]  

  • 13. Interelationships between dopaminergic and cholinergic systems in the cerebral cortex.
    Mantovani P; Bartolini A; Pepeu G
    Adv Biochem Psychopharmacol; 1977; 16():423-7. PubMed ID: 883550
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blocking of ACTH release from the pituitary gland with chlorpromazine].
    Amorim A
    Rev Bras Biol; 1968 Sep; 28(3):331-6. PubMed ID: 4317921
    [No Abstract]   [Full Text] [Related]  

  • 15. [Increased sensitivity of hypophyseal cells from neonatal rats to bromocriptine and melatonin].
    Gudoshnikov VI; Fedotov VP
    Biull Eksp Biol Med; 1993 Feb; 115(2):197-9. PubMed ID: 8043808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-dopa, chlorpromazine and apomorphine on brain monoamines and free amino acids in rats.
    Koyuncuoğlu H; Atamer-Simşek S; Keyer-Uysal M
    Pharmacol Res Commun; 1981 Sep; 13(8):787-95. PubMed ID: 7291284
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
    Molinatti GM; Camanni F; Massara F; Isaia GC
    Panminerva Med; 1975 Apr; 17(4):101-6. PubMed ID: 1153217
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin release.
    Caine E; Kartzinel R; Ebert M; Carter AC
    Life Sci; 1978 Mar; 22(10):911-8. PubMed ID: 147978
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug effect on cholinergic mechanisms in the cerebral cortex.
    Pepeu G
    Ann Ist Super Sanita; 1978; 14(1):157-62. PubMed ID: 756729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary function in 20 cases of prolactinoma in females.
    Eşanu C; Klepsch I; Calciu G; Bucur D; Popescu LG
    Endocrinologie; 1983; 21(2):131-9. PubMed ID: 6408728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.